Recursion Pharmaceuticals, Inc. ( RXRX) - Key Metrics
RXRX Revenue per Share metrics
| Date | Revenue per Share | Net Income per Share | Operating Cash Flow | Free Cash Flow per Share |
|---|---|---|---|---|
| 2026Q2 | $0.01 | -$0.25 | -$0.35 | -$0.35 |
| 2026Q1 | $0.01 | -$0.22 | -$0.15 | -$0.15 |
| 2025Q4 | $0.07 | -$0.21 | -$0.09 | -$0.09 |
| 2025Q3 | $0.01 | -$0.36 | -$0.26 | -$0.26 |
| 2025Q2 | $0.05 | -$0.41 | -$0.18 | -$0.19 |
RXRX Payout ratio and Price per Earnings ratio
| Date | Payout ratio | PE ratio |
|---|---|---|
| 2026Q2 | 0% | -3.67 |
| 2026Q1 | 0% | -3.49 |
| 2025Q4 | 0% | -4.87 |
| 2025Q3 | 0% | -3.39 |
| 2025Q2 | 0% | -3.09 |
RXRX
Price: $3.16
52 week price:
Earnings Per Share: -1.02 USD
Exchange: NMS
Sector: Healthcare
Industry: Biotechnology
Country: United States
Volume: 732400
Market Capitalization: 1.8 billion